1. Home
  2. BLMN vs OCS Comparison

BLMN vs OCS Comparison

Compare BLMN & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bloomin' Brands Inc.

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$7.87

Market Cap

674.3M

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$9.07

Market Cap

732.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLMN
OCS
Founded
1988
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
674.3M
732.4M
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
BLMN
OCS
Price
$7.87
$9.07
Analyst Decision
Hold
Strong Buy
Analyst Count
8
6
Target Price
$7.88
★ $42.00
AVG Volume (30 Days)
★ 1.9M
170.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
★ 4.99%
N/A
EPS Growth
★ 106.71
N/A
EPS
★ 1.01
N/A
Revenue
★ $4,213,346,000.00
N/A
Revenue This Year
$2.07
$466.06
Revenue Next Year
$1.81
$479.73
P/E Ratio
$7.80
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.19
$9.10
52 Week High
$12.63
$34.48

Technical Indicators

Market Signals
Indicator
BLMN
OCS
Relative Strength Index (RSI) 33.99 25.16
Support Level $7.79 N/A
Resistance Level $8.74 $12.97
Average True Range (ATR) 0.44 0.63
MACD -0.07 -0.12
Stochastic Oscillator 10.35 6.23

Price Performance

Historical Comparison
BLMN
OCS

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: